Evidence map›Paper›PMID 19602204›Full record

ArticleTraffic (Copenhagen, Denmark)2009

Adaptor protein-2 interaction with arrestin regulates GPCR recycling and apoptosis.

Brant M Wagener, Nicole A Marjon, Chetana M Revankar, Eric R Prossnitz

Open access · bronzeAbstract read
In one paragraph

Article in Traffic (Copenhagen, Denmark), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Phosphodiesterase 4 mediates interleukin-8-induced heterologous desensitization of the βFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Arrestins in apoptosis.Handbook of experimental pharmacology · 2014
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Brant M WagenerDepartment of Cell Biology and Physiology and UNM Cancer Research and Treatment Center, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Nicole A Marjon
Chetana M Revankar
Eric R Prossnitz
New Mexico Cancer Center · USUniversity of New Mexico · US

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
Regulation of Chemoattractant Receptor ActivationR01AI036357 · NIAID · UNIVERSITY OF NEW MEXICO · PI PROSSNITZ, ERIC R · 2001 to 2005
$1.7M
Arrestin activation probed with mass spectrometryR01GM068901 · NIGMS · UNIVERSITY OF NEW MEXICO · PI PROSSNITZ, ERIC R · 2004 to 2007
$1.1M
META DETECTOR &405 NM LASER: TUBERCULOSIS, PSEUDOMONAS IN CF REGULATION OF MUCOS10RR019287 · NCRR · UNIVERSITY OF NEW MEXICO · PI WANDINGER-NESS, ANGELA · 2004 to 2004
$363k
A CONFOCAL MICROSCOPE FOR HEALTH SCIENCES RESEARCHS10RR014668 · NCRR · UNIVERSITY OF NEW MEXICO · PI WANDINGER-NESS, ANGELA · 2000 to 2000
$300k
Zeiss Axiovert 2000 for Live Cell ImagingS10RR016918 · NCRR · UNIVERSITY OF NEW MEXICO · PI WANDINGER-NESS, ANGELA · 2002 to 2002
$135k
REGULATION OF CHEMOATTRACTANT RECEPTOR ACTIVATIONR29AI036357 · NIAID · UNIVERSITY OF NEW MEXICO · PI PROSSNITZ, ERIC R · 1994 to 1998
–
ENHANCING MULTIDISCIPLINARY BIOMEDICAL RESEARCHP20RR011830 · NCRR · UNIVERSITY OF NEW MEXICO · PI EATON, R P · 1996 to 1998
–
NCI NIH HHS P30 CA118100NCRR NIH HHS 1 S10 RR14668NCRR NIH HHS P20 RR11830NCRR NIH HHS S10 RR016918NCRR NIH HHS S10 RR019287NCRR NIH HHS S10 RR19287NIAID NIH HHS AI36357NIAID NIH HHS R01 AI036357NIAID NIH HHS R29 AI036357NIGMS NIH HHS GM68901NIGMS NIH HHS R01 GM068901
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are integral to cellular function in nearly all physiologic and many pathologic processes. GPCR signaling represents an intricate balance between receptor activation, inactivation (desensitization, internalization and degradation) and resensitization (recycling and de novo synthesis). Complex formation between phosphorylated GPCRs, arrestins and an ever-increasing number of effector molecules is known to regulate cellular function. Previous studies have demonstrated that, although N-formyl peptide receptor (FPR) internalization occurs in the absence of arrestins, FPR recycling is arrestin-dependent. Furthermore, FPR stimulation in the absence of arrestins leads to receptor accumulation in perinuclear endosomes and apoptosis. In this study, we show that the interaction of GPCR-bound arrestin with adaptor protein-2 (AP-2) is a critical anti-apoptotic event. In addition, AP-2 associates with the receptor-arrestin complex in perinuclear endosomes and is required for proper post-endocytic GPCR trafficking. Finally, we observed that depletion of endogenous AP-2 results in the initiation of apoptosis upon stimulation of multiple GPCRs, including P2Y purinergic receptors and CXCR2, but not CXCR4. We propose a model in which the abnormal accumulation of internalized GPCR-arrestin complexes in recycling endosomes, resulting from defective arrestin-AP-2 interactions, leads to the specific initiation of aberrant signaling pathways and apoptosis.

Indexed as

Adaptor Protein Complex 2ApoptosisArrestinsBlotting, WesternEndosomesGreen Fluorescent ProteinsHumansImmunoprecipitationMicroscopy, FluorescenceProtein BindingProtein TransportReceptors, Formyl PeptideReceptors, G-Protein-CoupledTransfectionU937 CellsAdaptor Protein Complex 2ArrestinsGreen Fluorescent ProteinsReceptors, Formyl PeptideReceptors, G-Protein-Coupled

Identifiers

PMID19602204
PMCPMC2923382
OpenAlexW2076061787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.